Tirzepatide Insurance Coverage: Zepbound vs Mounjaro PA Rules
Insurance covers the tirzepatide brands differently: the diabetes brands are on most drug lists with prior authorization, while the weight-loss brands are covered only when your plan includes weight-loss drugs.
- Plans tracked
- 18
- Self-pay if denied
- $299 a month
A quick look at Zepbound
The half-life is 5 to 6 days: 5.5 d leaves half behind, with about 3% still present at five half-lives (27.5 d).
SURMOUNT-1 ran for 72 weeks, and weight loss reached 20.9% of body weight, while the placebo group recorded 3.1%.
Monthly US dollar prices include list prices and self-pay offers, each taken from the maker's price page.
Sources: FDA label (DailyMed), Eli Lilly 1 2, cnbc.com.
Does insurance cover tirzepatide?
| Plan | For weight loss | For type 2 diabetes | Prior authorization |
|---|---|---|---|
| Medicare | Bridge program only | Covered by Part D plans | Required |
| Medicaid | Varies by state | Covered | Required |
| Plan dependent | Covered on formulary | Required | |
| Plan dependent | Covered on formulary | Required | |
| Plan dependent | Covered on formulary | Required | |
| Employer option | Covered on formulary | Required | |
| Plan dependent | Covered on formulary | Required | |
| Plan sponsor choice | Covered on formulary | Required | |
| Express Scripts | Plan sponsor choice | Covered on formulary | Required |
| Optum Rx | Plan sponsor choice | Covered on formulary | Required |
| Bridge program only | Covered by Part D plans | Required | |
| TRICARE | Prime and Select only | Covered with PA | Required |
| VA (Veterans Health Administration) | Covered with criteria | Covered | Required |
| Covered with PA | Covered | Required | |
| Excluded | Covered on formulary | Required | |
| ACA Marketplace plans | Rare | Common | Required |
| Plan sponsor choice | Covered on formulary | Not listed | |
| Follows state Medicaid | Covered with PA | Required |
Plan policies (18)
medicare.gov, KFF 1 2, aetna.com, static.cigna.com, uhcprovider.com, bluecrossma.org, healthy.kaiserpermanente.org, cvshealth.com, express-scripts.com, welcome.optumrx.com, humana.com, militaryrx.express-scripts.com, va.gov, geha.com, ambetterhealth.com, navitus.com, provider.amerigroup.com.
The published policy
- Medicare: The Bridge drug list includes Foundayo and Wegovy, Zepbound KwikPen
- CVS Caremark, Zepbound: It left the template formulary on July 1, 2025
- For CVS Caremark, Zepbound, October 1, 2026 marked its return as a preferred option
- Express Scripts, Excluded: No weight-loss coverage applies to Zepbound KwikPens or vials
- Medicare exclusions under Not in the Bridge apply to vials and single-dose pens
- Cigna add-on with a Copay cap of $200 each month (employer add-on)
- Unless an employer retained coverage, it was dropped in 2026 for Blue Cross Blue Shield, Blue Cross Massachusetts
- Weight-loss coverage: Optum Rx, CHAMPVA, Not covered
Sources: humana.com, medicare.gov, CMS, aetna.com.
A checklist for prior authorization
| Plan | Weight rule | Lifestyle program | To keep coverage |
|---|---|---|---|
| The baseline is BMI 30 or higher, or BMI 27 or higher with a weight-related condition | 6 months of a weight program first | 5% of baseline weight lost to renew | |
| BMI 27 or higher with a weight-related condition | Not listed | 5% weight loss after 3 months | |
| BMI 27 or higher with a weight-related condition | Not listed | Not listed | |
| With BMI 35 or above, a weight-related condition is required (Horizon NJ) | Not listed | Not listed | |
| VA (Veterans Health Administration) | BMI 27 or higher with a weight-related condition | Not listed | Not listed |
| BMI 27 or higher with established heart disease | Not listed | Not listed |
- Your height and weight, as measured, plus the BMI calculated from them.
- Conditions in your record that relate to weight, such as high cholesterol and also high blood pressure.
- A record of notes covering the diet and activity program that you tried.
Sources: aetna.com, static.cigna.com, uhcprovider.com, horizonblue.com.
The appeal, if you are denied
| Denial reason | What to send or ask |
|---|---|
| Criteria not met | Ask your prescriber to resubmit it using your measured BMI and a chart list of all weight-related conditions. |
| The drug is not on the plan's list | Request a formulary exception, and ask which GLP-1 the plan prefers instead. |
- Get the denial letter, which identifies the exact rule that was not met.
- With the appeal, your prescriber sends chart notes that address the rule.
- If the plan's appeal fails, ask for an external review by an independent reviewer.
Differences between states and plans
One state or employer plan from the same insurer may cover you while another does not.
- Unless an employer retained coverage, it was dropped in 2026 for Blue Cross Blue Shield, Blue Cross Massachusetts
- The exclusion described here has no appeal option: Blue Cross Blue Shield, Appeal: No appeal
- Blue Cross Blue Shield, Horizon (New Jersey) weight rule: With BMI 35 or above, a weight-related condition is required (Horizon NJ)
- In New Jersey, the Blue Cross Blue Shield, Horizon rule takes effect January 1, 2026
- For Blue Cross Blue Shield, Federal Employee Program, the policy date is October 1, 2026
- Kaiser Permanente, When coverage applies: whether you are covered depends on the benefit
- A cash price applies to Kaiser Permanente, Members without the benefit
- For Type 2 diabetes treatment, TRICARE coverage requires PA
Each state sets its own Medicaid rules. GLP-1s for weight loss have coverage now in 10 states: Delaware, Kansas, Michigan, Minnesota, Mississippi, Missouri, North Carolina, Tennessee, Virginia and Wisconsin. Compare every state side by side.
Sources: bluecrossma.org, horizonblue.com, info.caremark.com, healthy.kaiserpermanente.org.
Other choices if coverage says no
Sources: pricinginfo.lilly.com, mounjaro.lilly.com, GoodRx, zepbound.lilly.com.